KARL STORZ completes acquisition of Asensus Surgical

KARL STORZ acquired Asensus Surgical for $0.35 per share in cash, making Asensus a subsidiary. The deal closed after stockholder approval, combining Asensus's robotic surgery technology with KARL STORZ's endoscopy portfolio.

“By joining forces with a leading company in endoscopy that became a system provider for integrated MedTech, we are well-positioned to accelerate the development and delivery of our innovative robotic and digital surgical solutions.”markets.ft.com

• 1 source
• markets.ft.comAsensus Surgical Announces Closing of Acquisition by KARL STORZ – Company Announcement - FT.comAug 22, 2024

Summarized from public sources; check the original articles before acting on it.